CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+17.92%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$12.6B
AUM Growth
+$2.03B
(+19%)
Cap. Flow
+$572M
Cap. Flow
% of AUM
4.53%
Top 10 Holdings %
Top 10 Hldgs %
21.15%
Holding
884
New
80
Increased
408
Reduced
262
Closed
66
Top Buys
| 1 |
Apple
AAPL
|
$161M |
| 2 |
Salesforce
CRM
|
$59.9M |
| 3 |
Merck
MRK
|
$59.1M |
| 4 |
Citigroup
C
|
$56.5M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$52.3M |
Top Sells
| 1 |
Amazon
AMZN
|
$77.9M |
| 2 |
VSLR
VIVINT SOLAR, INC.
VSLR
|
$35.6M |
| 3 |
Apellis Pharmaceuticals
APLS
|
$33.9M |
| 4 |
Kodiak Sciences
KOD
|
$32.4M |
| 5 |
ADSW
Advanced Disposal Services, Inc.
ADSW
|
$31.7M |
Sector Composition
| 1 | Healthcare | 34.01% |
| 2 | Technology | 22.68% |
| 3 | Consumer Discretionary | 9.38% |
| 4 | Financials | 7.85% |
| 5 | Communication Services | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
EPAM Systems
EPAM
$9.44B
| $9.07M | 0.07% |
25,300
-3,000
| -11% | -$1.08M |
|
277
Hasbro
HAS
$11.2B
| $9.05M | 0.07% |
+96,727
| New | +$9.05M |
|
|
HMSY
278
DELISTED
HMS Holdings Corp.
HMSY
| $9.04M | 0.07% |
+245,943
| New | +$9.04M |
|
279
Y-mAbs Therapeutics
YMAB
$390M
| $8.91M | 0.07% |
179,946
-2,758
| -2% | -$137K |
|
|
EIDX
280
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $8.89M | 0.07% |
67,551
-118,170
| -64% | -$15.5M |
|
281
Ardelyx
ARDX
$1.57B
| $8.88M | 0.07% |
1,372,217
+734,574
| +115% | +$4.75M |
|
|
CIXX
282
DELISTED
CI Financial Corp.
CIXX
| $8.88M | 0.07% |
+716,686
| New | +$8.88M |
|
283
Baker Hughes
BKR
$44.9B
| $8.79M | 0.07% |
421,457
+57,097
| +16% | +$1.19M |
|
284
Monster Beverage
MNST
$61B
| $8.78M | 0.07% |
189,936
+1,688
| +0.9% | +$78.1K |
|
285
Edwards Lifesciences
EW
$47.5B
| $8.78M | 0.07% |
96,190
+8,927
| +10% | +$814K |
|
286
Fastenal
FAST
$55.1B
| $8.77M | 0.07% |
359,070
-8,850
| -2% | -$216K |
|
287
Etsy
ETSY
$5.36B
| $8.75M | 0.07% |
49,152
+43,329
| +744% | +$7.71M |
|
288
Mondelez International
MDLZ
$79.9B
| $8.72M | 0.07% |
149,200
+1,964
| +1% | +$115K |
|
289
Dell
DELL
$84.4B
| $8.7M | 0.07% |
234,229
+72,607
| +45% | +$2.7M |
|
290
Manulife Financial
MFC
$52.1B
| $8.65M | 0.07% |
486,491
+131,372
| +37% | +$2.34M |
|
291
Micron Technology
MU
$147B
| $8.65M | 0.07% |
105,179
+540
| +0.5% | +$44.4K |
|
292
Norfolk Southern
NSC
$62.3B
| $8.57M | 0.07% |
36,069
+16,236
| +82% | +$3.86M |
|
293
Kimberly-Clark
KMB
$43.1B
| $8.51M | 0.07% |
63,142
-11,108
| -15% | -$1.5M |
|
294
Immunovant
IMVT
$2.99B
| $8.4M | 0.07% |
181,749
-38,251
| -17% | -$1.77M |
|
295
Moody's
MCO
$89.5B
| $8.38M | 0.07% |
28,861
-23,681
| -45% | -$6.87M |
|
296
Fair Isaac
FICO
$36.8B
| $8.38M | 0.07% |
+16,389
| New | +$8.38M |
|
297
Canadian National Railway
CNI
$60.3B
| $8.34M | 0.07% |
75,955
+32,253
| +74% | +$3.54M |
|
298
AstraZeneca
AZN
$253B
| $8.17M | 0.06% |
163,468
+44,363
| +37% | +$2.22M |
|
299
Novavax
NVAX
$1.28B
| $8.09M | 0.06% |
72,549
+23,974
| +49% | +$2.67M |
|
300
GE Aerospace
GE
$296B
| $8.07M | 0.06% |
149,938
+21,451
| +17% | +$1.15M |
|